ChemicalBook >> CAS DataBase List >>ticilimumab tremelimumab
ticilimumab tremelimumab
- CAS No.
- 745013-59-6
- Chemical Name:
- ticilimumab tremelimumab
- Synonyms
- Ticilimumab;Tremelimumab;ticilimumab tremelimumab;Tremelimumab (anti-CTLA-4);Research Grade Ticilimumab (DHD17204);Research Grade Tremelimumab (DHD17203)
- CBNumber:
- CB41518542
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
Last updated:2023-05-21 10:59:17
storage temp. | Store at -20°C |
---|---|
NCI Dictionary of Cancer Terms | tremelimumab |
FDA UNII | QEN1X95CIX |
NCI Drug Dictionary | tremelimumab |
ticilimumab tremelimumab Preparation Products And Raw materials
Raw materials
Preparation Products
ticilimumab tremelimumab Suppliers
Global( 13)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Aladdin Scientific | +1-+1(833)-552-7181 | sales@aladdinsci.com | United States | 57511 | 58 |
Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10054 | 58 |
Beijing HuaMeiHuLiBiological Chemical | 010-56205725 | waley188@sohu.com | China | 12338 | 58 |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9709 | 58 |
ShangHai Biochempartner Co.,Ltd | 17754423994 17754423994 | 2853530910@QQ.com | China | 8015 | 62 |
AntibodySystem | 027-65279366 18162686757 | biolab-reagents@atagenix.com | China | 9817 | 58 |
Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 13720134139 | orders@jknbiochem.com | China | 5279 | 58 |
Shanghai Aladdin Biochemical Technology Co.,Ltd. | +86-18521732826 | market@aladdin-e.com | China | 48467 | 58 |
Changsha Fuzhen Biotechnology Co.,LTD | 0731-18670069958 18670069958 | 184792226@qq.com | China | 3060 | 58 |
Olix (Shanghai) Pharmaceutical Technology Co., Ltd | 17316404525 | 209533805@qq.com | China | 9620 | 58 |
745013-59-6(ticilimumab tremelimumab)Related Search:
ticilimumab tremelimumab
Ticilimumab
Tremelimumab
Research Grade Tremelimumab (DHD17203)
Research Grade Ticilimumab (DHD17204)
Tremelimumab (anti-CTLA-4)
745013-59-6